Four years of long-term data confirm the continued safety of the drug tildrakizumab in patients with psoriatic arthritis.
CHICAGO — Rosnilimab, a novel pathogenic T-cell depleting drug, met its primary endpoint of changes in DAS28 C-reactive ...
A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody ...
A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult ...
A friend just underwent a rotator cuff repair and is recovering well. But I was wondering, what if you get to a point where ...
While weight loss can help relieve joint pain in certain instances, the way you lose weight might be more important. The nutrients you eat are essential for joint and overall health. One diet that ...
News Medical on MSN
Tec-Dara could represent a new standard of care for relapsed or refractory multiple myeloma
Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback